What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
This article was originally published in The Pink Sheet
Executive Summary
Nonprescription Drug and the Drug Safety and Risk Management advisory committees jointly vote 15-5 that combining antacid with aspirin, acetaminophen or other analgesic ingredients is not a combination that should be allowed under an OTC monograph.